A detailed history of Concourse Financial Group Securities, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 7,841 shares of BSX stock, worth $603,835. This represents 0.04% of its overall portfolio holdings.

Number of Shares
7,841
Previous 7,271 7.84%
Holding current value
$603,835
Previous $420,000 27.86%
% of portfolio
0.04%
Previous 0.03%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$57.6 - $68.62 $32,832 - $39,113
570 Added 7.84%
7,841 $537,000
Q4 2023

Feb 07, 2024

SELL
$48.64 - $57.81 $4,961 - $5,896
-102 Reduced 1.38%
7,271 $420,000
Q3 2023

Oct 25, 2023

SELL
$50.19 - $54.68 $21,230 - $23,129
-423 Reduced 5.43%
7,373 $389,000
Q2 2023

Aug 10, 2023

BUY
$49.72 - $54.64 $142,050 - $156,106
2,857 Added 57.85%
7,796 $421,000
Q1 2023

May 15, 2023

BUY
$45.09 - $50.03 $86,392 - $95,857
1,916 Added 63.38%
4,939 $247,000
Q4 2022

Jan 30, 2023

SELL
$39.56 - $47.22 $10,325 - $12,324
-261 Reduced 7.95%
3,023 $0
Q3 2022

Nov 15, 2022

SELL
$36.71 - $109.66 $11,159 - $33,336
-304 Reduced 8.47%
3,284 $127,000
Q2 2022

Aug 09, 2022

SELL
$35.24 - $47.1 $18,113 - $24,209
-514 Reduced 12.53%
3,588 $134,000
Q1 2022

May 09, 2022

SELL
$40.9 - $45.1 $30,552 - $33,689
-747 Reduced 15.41%
4,102 $182,000
Q4 2021

Feb 07, 2022

BUY
$38.07 - $44.87 $4,301 - $5,070
113 Added 2.39%
4,849 $206,000
Q3 2021

Nov 09, 2021

BUY
$41.23 - $45.88 $49,352 - $54,918
1,197 Added 33.82%
4,736 $205,000
Q2 2021

Aug 13, 2021

BUY
$38.58 - $44.24 $1,350 - $1,548
35 Added 1.0%
3,539 $151,000
Q1 2021

May 13, 2021

SELL
$35.27 - $39.67 $58,618 - $65,931
-1,662 Reduced 32.17%
3,504 $135,000
Q4 2020

Feb 02, 2021

SELL
$33.15 - $41.97 $328,814 - $416,300
-9,919 Reduced 65.75%
5,166 $186,000
Q3 2020

Nov 13, 2020

BUY
$34.44 - $42.23 $46,184 - $56,630
1,341 Added 9.76%
15,085 $576,000
Q2 2020

Aug 13, 2020

BUY
$30.19 - $39.11 $49,692 - $64,375
1,646 Added 13.61%
13,744 $483,000
Q1 2020

May 13, 2020

SELL
$25.83 - $45.71 $39,649 - $70,164
-1,535 Reduced 11.26%
12,098 $395,000
Q4 2019

Feb 14, 2020

BUY
$37.87 - $45.37 $332,687 - $398,575
8,785 Added 181.21%
13,633 $616,000
Q3 2019

Nov 13, 2019

BUY
$40.31 - $43.45 $21,283 - $22,941
528 Added 12.22%
4,848 $197,000
Q2 2019

Aug 13, 2019

BUY
$34.91 - $42.98 $34,875 - $42,937
999 Added 30.08%
4,320 $186,000
Q1 2019

May 15, 2019

SELL
$32.91 - $40.75 $76,087 - $94,214
-2,312 Reduced 41.04%
3,321 $127,000
Q4 2018

Feb 14, 2019

BUY
$31.73 - $39.04 $152,050 - $187,079
4,792 Added 569.8%
5,633 $199,000
Q3 2018

Nov 13, 2018

BUY
$32.83 - $38.63 $27,610 - $32,487
841 New
841 $32,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $110B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.